What an insult that Wolgen refers to market / economic conditions in his letter to the shareholders as some excuse for the terrible share price performance.
Does he think we've lived under a rock since March 2009 and are unaware of the amazing stock market recovery since then? Does he think there is only tepid interest in biotech / pharma stocks? Has he been aware of how well some investors have done in biotech / pharma investments recently?
There have been MANY winning stocks in biotech / pharma the past couple years - too many to mention.
NOT ONCE have I heard Wolgen take responsibility for the dismal stock performance of cuv under his helm. Not once.
IMO, there have been key judgment errors made here.
CUV Price at posting:
$1.65 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)